|
Sinoatrial (SA) Node Dysfunction
The normal
pacemaker of the heart, termed the sinus (or sinoatrial (SA)) node,
is responsible for generating the electrical impulse that triggers the
heart to contract and pump blood. Normally the SA node "fires-off" at
regular intervals ranging from 40 to 170 discharges/min. This wide range
of rates corresponds with the wide activity levels that humans engage
in and the wide range in demands for cardiac output. For example, when
we sleep we don't need high levels of cardiac pumping of blood and so
our heart rate reaches its lowest levels, sometimes as low as 30-40 beats/min.
On the other hand, during peak exercise activity, we need all the cardiac
output our heart can muster to deliver oxygenated blood to our heart,
brain, muscles, and other tissues, and remove waste products such as
carbon dioxide. Consequently, under these conditions our sinus rate approaches
its maximum achievable level.
Patients with SA node dysfunction often exhibit more than one of the following
abnormalities:
- Symptomatic severe sinus bradycardia (sinus rates < 40/min resting
while awake (excluding well conditioned athletes)).
- Severe chronotropic incompetence (absence of the expected increase
in sinus rate increase during exercise) in association with with symptoms
of early fatigue with minimal exertion.
- Significant sinus arrest or sinus pauses, especially in association
with symptoms such as fainting or "dizzy" spells.
- Episodes of bradycardia or sinus pauses (as described above) following
termination of and/or interspersed with episodes of paroxysmal atrial
tachyarrhythmias, especially atrial
flutter or atrial
fibrillation.
Most
cases of sinus node dysfunction is the result of fixed damage
to or degeneration of sinoatrial tissue and it is typically seen in the
elderly or patients with significant structural heat disease, including
coronary artery disease, congestive heart failure, or cardiomyopathy.
As mentioned above, it is often associated with atrial tachyarrhythmias
such as atrial fibrillation or flutter. In some cases, sinus node dysfunction
may be secondary to, or worsened by, medications (see table 1 below)
that the patient may be taking for control of other cardiovascular problems,
including supraventricular
tachyarrhythmias, ventricular
tachyarrhythmias, hypertension (high blood pressure), coronary artery
disease, or congestive heart failure. It is not unusual to have brief
transient episodes of marked sinus bradycardia or symptomatic sinus pauses
caused by vasovagal episodes in patients without any fixed conduction
system or cardiovascular disease.
Table 1. Cardiovascular medications
that may adversely affecting sinus node function
| Class
of Medication |
Examples |
| Cardiac
glycosides |
Digoxin,
digitoxin, digitalis |
| Sympatholytic
agents |
Alpha-methyldopa,
clonidine |
| Betaadrenergic
blocking agents |
Propranolol,
atenolol, nadolol, etc. |
| Calcium
channel blocking agents |
Verapamil,
diltiazem, nifedipine |
| Antiarrhythmic
drugs |
Quinidine,
procainamide, flecainide, propafenone, sotalol, amiodarone |
| Miscellaneous
agents |
Lithium
carbonate, cimetidine, amitriptyline, phenothiazines |
Clinical diagnosis of sinus node dysfunction is made by correlating
suspicious symptoms ("dizziness", fatigue, shortness of breath,
etc.) with ECG recordings of dramatically
slow heart rates (Figure 1 below), including very slow sinus rates, so-called "slow
junctional escape rhythms", and/or prolonged pauses in the heart rate,
or inability of the heart rate to increase during exercise or exertion.

Figure 1. Continuous ECG recording (ECG lead V2) showing characteristic ECG
findings in patient with symptomatic sinoatrial node dysfunction. PAC =
premature atrial contraction.
Treatment for SA node dysfunction includes elimination of any offending medication
(Table 1 above), and if necessary, implantation of a pacemaker
system. Patients with symptomatic sinus pauses caused by vasovagal
episodes rarely need treatment with a pacemaker; instead recurrent problematic
episodes may be treatable with lifestyle modification and/or mild medications. |